The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

chnpharmahub.com

Stage

Unattributed VC | Dead

Total Raised

$500K

Last Raised

$500K

About China PharmaHub

China PharmaHub Corp. ("PharmaHub") is a global pharmaceutical HUB specializing in the identification, development and marketing of pharmaceutical and healthcare products that make a significant difference to patients and society.

China PharmaHub Headquarter Location

Diamond Bar, California, 91765,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing China PharmaHub

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

China PharmaHub is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

  • Where is China PharmaHub's headquarters?

    China PharmaHub's headquarters is located at Diamond Bar.

  • What is China PharmaHub's latest funding round?

    China PharmaHub's latest funding round is Unattributed VC.

  • How much did China PharmaHub raise?

    China PharmaHub raised a total of $500K.

  • Who are China PharmaHub's competitors?

    Competitors of China PharmaHub include Rafael Pharmaceuticals, Aegerion Pharmaceuticals, NextWave Pharmaceuticals, Salix Pharmaceuticals, Ikaria and 12 more.

You May Also Like

E
Esperance Pharmaceuticals

Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.

A
AkaRx

AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.

P
Presidio Pharmaceuticals

Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for hepatitis C virus (HCV) infection. With a pipeline consisting of compounds targeting both the NS5A and NS5B proteins of HCV, Presidio is positioned to compete in the growing HCV therapy market. Presidio's goal is to discover and advance small-molecule, antiviral drug candidates that are potent, have pan-genotypic antiviral activity, offer convenient once-daily oral dosing and can be combined with other classes of HCV antivirals to combat viral resistance. The best future combination regimens will require such characteristics, to simplify patient treatment and to ensure that drug therapy will be effective against the wide variety of known HCV genotypes.

A
Albea Pharmaceuticals

Through a series of acquisitions, Albea Pharmaceuticals intends to build a rapidly growing, profitable, and pan-European pharmaceutical company with a portfolio of marketed products, a direct sales and marketing organization in the major European countries (UK, Germany, France, Italy and Spain), and a pipeline of products in various stages of clinical development.'

O
Oncology Research Therapeutics

Oncology Research Therapeutics, Inc. is dedicated to providing and discovering cancer diagnostics that improve the lives of patients suffering from a wide array of cancers. They also provide R&D services that improve drug development for the Biotech and Pharmaceutical industries.

G
GC-Rise Pharmaceutical

GC-Rise Pharmaceutical is a pharmaceutical company that aims to bring Western natural medicine with proven clinical benefits to China. The company received approval for Remifemin for natural treatment for post-menoposal symptoms from the Chinese regulatory authorities (SFDA) after successfully conducting clinical trials in China. The company has launched other products and is currently developing additional natural derived medicine in China.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.